NOX1 and congenital rubella syndrome: Compared to the CRS group, meloxicam suppressed hippocampal pro-oxidant signals by significantly diminishing 8-OHdG, NOX1, and NOX4 by 49.3% (p < 0.0001, Tukey post hoc test), 55.8% (p < 0.0001, Tukey post hoc test), and 56.7% (p < 0.001, Tukey post hoc test), respectively.